Research News

Markey Hosting OncLive Summit on Neuroendocrine Tumors

Mar 18, 2019, 8:52 AM

The University of Kentucky Markey Cancer Center is hosting OncLive’s State of the Science Summit with a focus on neuroendocrine tumors on Saturday, April 20, 2019.

ACA Medicaid Expansion Increases Colon Cancer Screenings, Survival in Ky

Feb 25, 2019, 9:05 AM

A University of Kentucky study published in the Journal of the American College of Surgeons shows a direct link between the adoption of the Affordable Care Act (ACA) Medicaid expansion and the impact of colon cancer on Kentuckians.

Clinical Trial Gives UK Pathologist New Hope

Feb 5, 2019, 9:25 AM

As a pathologist at the University of Kentucky, Dr. Charles Lutz helps patients behind the scenes, matching patients who need both solid organ and bone marrow transplants with appropriate donors. But when he was diagnosed with an aggressive prostate cancer in 2011, Lutz found himself on the other side of the table.

UK Study Shows Promise Toward Prevention of Melanoma

Jan 15, 2019, 10:33 AM

In a study published in the Journal of Biological Chemistry, a team of University of Kentucky researchers have discovered specific protein interactions that may help cells resist ultraviolet (UV) damage and carcinogenesis.

Daret St. Clair Receives Lifetime Achievement Award from International Society

Nov 27, 2018, 9:25 AM

University of Kentucky Markey Cancer Center researcher Daret St. Clair, Ph.D., has been named the 2018 Lifetime Achievement Award Recipient from the Society for Redox Biology and Medicine (SfRBM).

Screen%20Shot%202018-11-19%20at%201.09.43%20PM.png

New NCI Grant Expands Markey’s Successful Oncology Training Program to High Schoolers

Nov 26, 2018, 8:51 AM

After successfully launching an oncology training program for Appalachian undergrads in 2016, the University of Kentucky Markey Cancer Center is expanding the program to include high school students.

UK Study Finds Promising Therapeutic Target for Aggressive Type of Breast Cancer

Nov 12, 2018, 9:31 AM

A new Nature Communications study led by University of Kentucky Markey Cancer Center researchers suggests that an enzyme known as Prolyl 4-hydroxylase subunit alpha-1 (P4HA1) is a potential therapeutic target for triple negative breast cancer.

20170412%20-%20Ren%20Xu%20COBRE%20Photos%20-%20A7R%20-%20002.JPG

A Promise We Intend to Keep

Nov 6, 2018, 8:30 AM

Kentucky faces the highest cancer incidence and mortality rates in the United States. Researchers at the University of Kentucky aim to reduce these numbers by half. We believe that’s what Kentucky can do.

United Health Foundation Awards $1 Million Grant to UK College of Dentistry to Reduce Oral Cancer, Improve Oral Health

Nov 2, 2018, 9:00 AM

A $1 million grant from the United Health Foundation will enable the University of Kentucky’s College of Dentistry to launch its “Eradicate Oral Cancer in Eastern Kentucky” project.

Study: Ultrasound Ovarian Cancer Screening Improves Survival

Nov 1, 2018, 9:37 AM

A University of Kentucky study just published in Obstetrics & Gynecology shows that annual ultrasound screening of at-risk asymptomatic women increases the survival rates of women with type I and type II epithelial ovarian cancer.

Filter News

Unit

News type

Topic

Series